Sign Out
XOFLUZA is indicated for the treatment of influenza in patients aged 12 and above who have been symptomatic for no more than 48 hours (see Pharmacology: Pharmacodynamics: Clinical/Efficacy Studies under Actions).
XOFLUZA is indicated for treatment of influenza in patients aged 12 and above who have been symptomatic for no more than 48 hours, and are at high risk of developing influenza complications.
Limitations of Use: Prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use XOFLUZA (see Pharmacology: Pharmacodynamics: Clinical/Efficacy Studies: Resistance Monitoring during Clinical Development under Actions).
Continue with Google